<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Palatino Linotype";
panose-1:2 4 5 2 5 5 5 3 3 4;}
@font-face
{font-family:"Gill Sans MT";
panose-1:2 11 5 2 2 1 4 2 2 3;}
@font-face
{font-family:"Franklin Gothic Book";
panose-1:2 11 5 3 2 1 2 2 2 4;}
@font-face
{font-family:"Myriad Pro";}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle19
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle20
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle21
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle22
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle23
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle24
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle25
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle26
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle27
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle28
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle29
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle30
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle31
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle32
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle33
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle34
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle35
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle36
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle37
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle38
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle39
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle40
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
p.Default, li.Default, div.Default
{mso-style-name:Default;
margin:0in;
margin-bottom:.0001pt;
text-autospace:none;
font-size:12.0pt;
font-family:"Gill Sans MT","sans-serif";
color:black;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span style='font-size:14.0pt'><o:p> </o:p></span></p><p class=MsoNormal align=center style='margin-bottom:12.0pt;text-align:center'><b><span style='font-size:14.0pt'>UH ChBE Dept. Seminar<br>10:30am-11:30am, Friday, January 20, 2017<br>Rm L2D2</span></b><span style='font-size:14.0pt'><o:p></o:p></span></p><p class=MsoNormal align=center style='text-align:center'><b><span style='font-size:20.0pt;font-family:"Palatino Linotype","serif"'>Engineering Functional Biomaterials: From Stem Cell Morphogenesis to Targeted Drug Delivery<o:p></o:p></span></b></p><p class=MsoNormal align=center style='text-align:center'><b><span style='font-size:18.0pt'>Donny Hanjaya-Putra, PhD<o:p></o:p></span></b></p><p class=MsoNormal align=center style='text-align:center'><b><span style='font-size:14.0pt'>Wyss Institute for Biologically Inspired Engineering<o:p></o:p></span></b></p><p class=MsoNormal align=center style='text-align:center'><b><span style='font-size:14.0pt'>Harvard Medical School, Boston MA<o:p></o:p></span></b></p><p class=MsoNormal align=center style='text-align:center'><b><o:p> </o:p></b></p><p class=MsoNormal><b><span style='font-size:14.0pt'><o:p> </o:p></span></b></p><p class=MsoNormal><o:p> </o:p></p><p class=Default><b><u><span style='font-size:14.0pt;color:windowtext'>ABSTRACT:</span></u></b><span style='font-size:14.0pt;color:windowtext'> </span><span style='color:windowtext'><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;text-indent:.5in;line-height:150%;text-autospace:none'> <span style='font-size:11.5pt;line-height:150%'>Functional biomaterials can be engineered with tunable physical and chemical properties to a range of applications in biotechnology, from bio-responsive hydrogels to targeted drug conjugate. The first part of my talk will focus on work completed during my graduate work aimed at development of biomaterials to control vascular morphogenesis from stem cells. The success of tissue engineering has been hindered by functional vascular networks to support the engineered-organs. To overcome this limitation, we developed synthetic polysaccharide hydrogels that provide spatial and temporal control for vascular morphogenesis. Consequently, generating these vascular beds from stem cells and synthetic polymer was proven to be useful in aiding the transplantation of tissue-engineered constructs into a range of vascular disorders. The second part of my talk will focus on our on-going efforts at developing strategies to limit thrombosis and inflammation in the context of venous thrombosis and stem cell transplantation. Despite recent advances in anticoagulation therapy, the rate of bleeding complication remains high, especially for patients with multiple risk factors. To address these challenges, we developed a fusion of protein and single-chain-antibody that combines potent anti-coagulation with platelet targeting. Using this unique approach, we inhibited thrombosis without altering systemic coagulation profiles. Collectively, these two examples illustrate that functional biomaterials are powerful and versatile platforms for various applications in biomedicine.</span><span style='font-size:14.0pt;line-height:150%;font-family:"Myriad Pro"'><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-size:14.0pt;font-family:"Palatino Linotype","serif"'><o:p> </o:p></span></p><p class=MsoNormal style='text-align:justify;text-indent:.25in;background:white'><span style='font-size:14.0pt;font-family:"Times New Roman","serif"'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><o:p> </o:p></span></p><p class=MsoNormal style='text-align:justify;text-indent:27.35pt;line-height:15.0pt;mso-line-height-rule:exactly'><span style='font-family:"Arial","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-size:14.0pt'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-size:14.0pt'><o:p> </o:p></span></p><p class=MsoNormal style='margin-right:2.25pt;text-align:justify;line-height:115%'><span style='font-size:14.0pt;line-height:115%'><o:p> </o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal style='text-align:justify'><o:p> </o:p></p><p class=MsoNormal style='text-align:justify'><o:p> </o:p></p><p class=MsoNormal style='text-align:justify;text-indent:12.05pt'><span style='font-family:"Franklin Gothic Book","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p></div></body></html>